VIRBAC: Croissance d
VIRBAC: Croissance du chiffre d’affaires de +6,8% à taux de change et périmètre constants à fin septembre 2020 (+5,6% à taux constants) grâce à une solide performance au troisième trimestre
14 oct. 2020 11h45 HE | Virbac
  CHIFFRES CLÉSChiffre d’affairesNeuf mois 2020713,9 M€Évolution globale+2,4%(+3,3% hors Sentinel)Croissance à taux de change constants+5,6% Croissance à taux de change et périmètre constants 1+6,8%...
Marel: Uppgjör þriðj
Marel: Uppgjör þriðja ársfjórðungs 2020 birt 20. október, rafrænn afkomufundur 21. október 2020
13 oct. 2020 11h02 HE | Marel hf.
Marel hf. mun birta uppgjör þriðja ársfjórðungs 2020 eftir lokun markaðar þann 20. október 2020. Rafrænn afkomufundur með markaðsaðilum Miðvikudaginn 21. október 2020 kl. 8:30 verður haldinn...
Marel: Q3 2020 resul
Marel: Q3 2020 results published on 20 October, virtual investor meeting on 21 October 2020
13 oct. 2020 11h02 HE | Marel hf.
Marel hf. will publish its Q3 2020 interim condensed consolidated financial statements after market closing on 20 October 2020. Earnings conference call and webcast On Wednesday 21 October 2020, at...
GCC med resol logo only.jpg
GCC Announces Q3 2020 Conference Call Details
07 oct. 2020 14h27 HE | Grupo Cementos De Chihuahua, S.A.B. De C.V.
CHIHUAHUA, Mexico, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Grupo Cementos de Chihuahua, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, will host a...
Logo TIGO MIC Blue.png
Notice of third quarter 2020 results and conference call
25 sept. 2020 08h00 HE | Millicom International Cellular S.A.
Notice of third quarter 2020 results and conference call  Luxembourg, September 25, 2020 – Millicom will announce its third quarter results on October 30, 2020 at approximately 11:00 (Stockholm)...
Minerva logo
Minerva Neurosciences to Report Second Quarter 2020 Financial Results and Business Updates on August 3, 2020
27 juil. 2020 08h00 HE | Minerva Neurosciences, Inc
WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...